secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001140361-23-060180
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STRATA Skin Sciences expands distribution agreement with Kosmo Meditech through 2026
--------------------------------------------------------------------------------

- Agreement with Cutech (Kosmo Meditech parent) extended through December 31, 2026 for direct capital and recurring revenue sales in Korea.
- Defined annual and quarterly performance-based purchase requirements, with STRATA becoming sole provider of gas and consumables.
- CPT codes 96920-96922 revised effective Jan 1, 2024 to 'Excimer laser treatment for psoriasis', impacting Medicare and potentially private insurers.
- STRATA's XTRAC and Pharos are the only excimer laser devices currently marketed in the US that meet the revised code description.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123060180/0001140361-23-060180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036123060180/ef20017695_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-060180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer